Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2

Chungyoul Choe1, Nanyue Chen, Michèle Sawadogo

  • 1Department of Molecular Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Experimental Cell Research
|November 16, 2004
PubMed

Insights

Transcription factor USF2 (upstream transcription factor 2) suppresses tumor growth by inhibiting c-Myc activity. This study demonstrates USF2

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Transcription Factors

Background:

  • USF (upstream transcription factor) is a family of bHLH-zip transcription factors with DNA binding similar to c-Myc.
  • USF plays a role in growth control, inhibiting c-Myc-dependent transformation.
  • USF transcriptional activity is lost in many cancer cell lines, but its direct effect on tumorigenicity is unproven.

Purpose of the Study:

  • To investigate the tumor suppressor ability of USF.
  • To determine the direct effect of USF on the tumorigenicity of established cell lines.

Main Methods:

  • Used rat embryo fibroblasts transformed by c-Ha-Ras and either c-Myc or E1A as a model system.
  • Overexpressed USF2 in transformed fibroblasts.
  • Constructed stable clones with high USF2 levels from c-Myc-transformed fibroblasts.
  • Assessed transcriptional activity, transformed phenotype, proliferation in soft agar, and tumor formation in nude mice.
  • Utilized USF- or Myc-specific dominant-negative mutants in cotransfection assays.

Main Results:

  • USF2 overexpression stimulated transcription and inhibited colony formation in c-Myc-transformed, but not E1A-transformed, fibroblasts.
  • Transcriptionally active USF2 in c-Myc-transformed fibroblasts led to altered morphology, decreased proliferation, and a >30-fold reduction in tumor formation in nude mice.
  • Inactive USF2 overexpression did not alter the transformed phenotype or tumorigenicity.
  • Active USF2 inhibited cellular transformation by preventing c-Myc-mediated transcriptional repression.

Conclusions:

  • Transcriptionally active USF2 exhibits tumor suppressor activity against c-Myc-driven transformation.
  • USF2 directly inhibits the tumorigenicity of established cancer cell lines.
  • USF2 functions, in part, by counteracting the transcriptional repression mediated by c-Myc.

Related Concept Videos